Shopping Cart 0
Cart Subtotal
AED 0

Global Postmenopausal Vaginal Atrophy Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Postmenopausal vaginal atrophy (PVA) refers to reduction in estrogen production after menopause and this condition is also called as vaginal atrophy. Less estrogen leads to thinning, drying, and decreased elasticity of vaginal tissues. Various other factors that lead to decrease in estrogen levels include perimenopause during breast feeding, surgical menopause, pelvic radiation therapy, and chemotherapy.

Scope of the Report:

This report focuses on the Postmenopausal Vaginal Atrophy Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Postmenopausal Vaginal Atrophy Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Actavis plc

Bionovo, Inc.

Endoceutics, Inc.

Novo Nordisk A/S

Pfizer Inc.

Teva Pharmaceuticals Ltd.

Therapeutics MD, Inc.

Shionogi & Company

Allergan plc

Shionogi & Co. Ltd.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Premarin

Vagifem

Estrace

Estring

Femring

Market Segment by Applications, can be divided into

Vaginal Gels

Creams

Tablets

Rings

Patches

There are 15 Chapters to deeply display the global Postmenopausal Vaginal Atrophy Drugs market.

Chapter 1, to describe Postmenopausal Vaginal Atrophy Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Postmenopausal Vaginal Atrophy Drugs, with sales, revenue, and price of Postmenopausal Vaginal Atrophy Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Postmenopausal Vaginal Atrophy Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Postmenopausal Vaginal Atrophy Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Postmenopausal Vaginal Atrophy Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Postmenopausal Vaginal Atrophy Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Premarin

1.2.2 Vagifem

1.2.3 Estrace

1.2.4 Estring

1.2.5 Femring

1.3 Market Analysis by Applications

1.3.1 Vaginal Gels

1.3.2 Creams

1.3.3 Tablets

1.3.4 Rings

1.3.5 Patches

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Actavis plc

2.1.1 Business Overview

2.1.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bionovo, Inc.

2.2.1 Business Overview

2.2.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Endoceutics, Inc.

2.3.1 Business Overview

2.3.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novo Nordisk A/S

2.4.1 Business Overview

2.4.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer Inc.

2.5.1 Business Overview

2.5.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Teva Pharmaceuticals Ltd.

2.6.1 Business Overview

2.6.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Therapeutics MD, Inc.

2.7.1 Business Overview

2.7.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Shionogi & Company

2.8.1 Business Overview

2.8.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Allergan plc

2.9.1 Business Overview

2.9.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Shionogi & Co. Ltd.

2.10.1 Business Overview

2.10.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Postmenopausal Vaginal Atrophy Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Postmenopausal Vaginal Atrophy Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Postmenopausal Vaginal Atrophy Drugs Market Analysis by Regions

4.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

4.5 South America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

5 North America Postmenopausal Vaginal Atrophy Drugs by Countries

5.1 North America Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6 Europe Postmenopausal Vaginal Atrophy Drugs by Countries

6.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6.3 UK Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6.4 France Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs by Countries

7.1 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7.5 India Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

8 South America Postmenopausal Vaginal Atrophy Drugs by Countries

8.1 South America Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs by Countries

9.1 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

10 Global Postmenopausal Vaginal Atrophy Drugs Market Segment by Type

10.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Type (2013-2018)

10.2 Premarin Sales Growth and Price

10.2.1 Global Premarin Sales Growth (2013-2018)

10.2.2 Global Premarin Price (2013-2018)

10.3 Vagifem Sales Growth and Price

10.3.1 Global Vagifem Sales Growth (2013-2018)

10.3.2 Global Vagifem Price (2013-2018)

10.4 Estrace Sales Growth and Price

10.4.1 Global Estrace Sales Growth (2013-2018)

10.4.2 Global Estrace Price (2013-2018)

10.5 Estring Sales Growth and Price

10.5.1 Global Estring Sales Growth (2013-2018)

10.5.2 Global Estring Price (2013-2018)

10.6 Femring Sales Growth and Price

10.6.1 Global Femring Sales Growth (2013-2018)

10.6.2 Global Femring Price (2013-2018)

11 Global Postmenopausal Vaginal Atrophy Drugs Market Segment by Application

11.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2013-2018)

11.2 Vaginal Gels Sales Growth (2013-2018)

11.3 Creams Sales Growth (2013-2018)

11.4 Tablets Sales Growth (2013-2018)

11.5 Rings Sales Growth (2013-2018)

11.6 Patches Sales Growth (2013-2018)

12 Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.2.2 Europe Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.2.4 South America Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.3 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Type (2018-2023)

12.4 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Postmenopausal Vaginal Atrophy Drugs Picture

Table Product Specifications of Postmenopausal Vaginal Atrophy Drugs

Figure Global Sales Market Share of Postmenopausal Vaginal Atrophy Drugs by Types in 2017

Table Postmenopausal Vaginal Atrophy Drugs Types for Major Manufacturers

Figure Premarin Picture

Figure Vagifem Picture

Figure Estrace Picture

Figure Estring Picture

Figure Femring Picture

Figure Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Applications in 2017

Figure Vaginal Gels Picture

Figure Creams Picture

Figure Tablets Picture

Figure Rings Picture

Figure Patches Picture

Figure United States Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Actavis plc Basic Information, Manufacturing Base and Competitors

Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bionovo, Inc. Basic Information, Manufacturing Base and Competitors

Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Endoceutics, Inc. Basic Information, Manufacturing Base and Competitors

Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors

Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Therapeutics MD, Inc. Basic Information, Manufacturing Base and Competitors

Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shionogi & Company Basic Information, Manufacturing Base and Competitors

Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Allergan plc Basic Information, Manufacturing Base and Competitors

Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shionogi & Co. Ltd. Basic Information, Manufacturing Base and Competitors

Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Manufacturer (2016-2017)

Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Manufacturer in 2016

Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Manufacturer in 2017

Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Manufacturer (2016-2017)

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Postmenopausal Vaginal Atrophy Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Postmenopausal Vaginal Atrophy Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Regions (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Regions (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Regions (2013-2018)

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions in 2013

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions in 2017

Figure North America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Europe Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure South America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table North America Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2013

Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017

Table North America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Table North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2013

Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017

Figure United States Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Canada Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table Europe Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Table Europe Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2016

Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017

Figure Germany Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure UK Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure France Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Russia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Italy Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries 2017

Figure China Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Japan Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Korea Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure India Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure South America Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table South America Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Figure South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017

Table South America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Table South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017

Figure Brazil Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure UAE Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Type (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Type (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Type (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Type (2013-2018)

Figure Global Premarin Sales Growth (2013-2018)

Figure Global Premarin Price (2013-2018)

Figure Global Vagifem Sales Growth (2013-2018)

Figure Global Vagifem Price (2013-2018)

Figure Global Estrace Sales Growth (2013-2018)

Figure Global Estrace Price (2013-2018)

Figure Global Estring Sales Growth (2013-2018)

Figure Global Estring Price (2013-2018)

Figure Global Femring Sales Growth (2013-2018)

Figure Global Femring Price (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Application (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Application (2013-2018)

Figure Global Creams Sales Growth (2013-2018)

Figure Global Tablets Sales Growth (2013-2018)

Figure Global Rings Sales Growth (2013-2018)

Figure Global Patches Sales Growth (2013-2018)

Figure Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Regions (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Figure Europe Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Figure South America Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Type (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Type (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Application (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Actavis plc

Bionovo, Inc.

Endoceutics, Inc.

Novo Nordisk A/S

Pfizer Inc.

Teva Pharmaceuticals Ltd.

Therapeutics MD, Inc.

Shionogi & Company

Allergan plc

Shionogi & Co. Ltd.

Postmenopausal vaginal atrophy (PVA) refers to reduction in estrogen production after menopause and this condition is also called as vaginal atrophy. Less estrogen leads to thinning, drying, and decreased elasticity of vaginal tissues. Various other factors that lead to decrease in estrogen levels include perimenopause during breast feeding, surgical menopause, pelvic radiation therapy, and chemotherapy.

Scope of the Report:

This report focuses on the Postmenopausal Vaginal Atrophy Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Postmenopausal Vaginal Atrophy Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Actavis plc

Bionovo, Inc.

Endoceutics, Inc.

Novo Nordisk A/S

Pfizer Inc.

Teva Pharmaceuticals Ltd.

Therapeutics MD, Inc.

Shionogi & Company

Allergan plc

Shionogi & Co. Ltd.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Premarin

Vagifem

Estrace

Estring

Femring

Market Segment by Applications, can be divided into

Vaginal Gels

Creams

Tablets

Rings

Patches

There are 15 Chapters to deeply display the global Postmenopausal Vaginal Atrophy Drugs market.

Chapter 1, to describe Postmenopausal Vaginal Atrophy Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Postmenopausal Vaginal Atrophy Drugs, with sales, revenue, and price of Postmenopausal Vaginal Atrophy Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Postmenopausal Vaginal Atrophy Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Postmenopausal Vaginal Atrophy Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Postmenopausal Vaginal Atrophy Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Postmenopausal Vaginal Atrophy Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Premarin

1.2.2 Vagifem

1.2.3 Estrace

1.2.4 Estring

1.2.5 Femring

1.3 Market Analysis by Applications

1.3.1 Vaginal Gels

1.3.2 Creams

1.3.3 Tablets

1.3.4 Rings

1.3.5 Patches

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Actavis plc

2.1.1 Business Overview

2.1.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bionovo, Inc.

2.2.1 Business Overview

2.2.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Endoceutics, Inc.

2.3.1 Business Overview

2.3.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novo Nordisk A/S

2.4.1 Business Overview

2.4.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer Inc.

2.5.1 Business Overview

2.5.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Teva Pharmaceuticals Ltd.

2.6.1 Business Overview

2.6.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Therapeutics MD, Inc.

2.7.1 Business Overview

2.7.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Shionogi & Company

2.8.1 Business Overview

2.8.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Allergan plc

2.9.1 Business Overview

2.9.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Shionogi & Co. Ltd.

2.10.1 Business Overview

2.10.2 Postmenopausal Vaginal Atrophy Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Postmenopausal Vaginal Atrophy Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Postmenopausal Vaginal Atrophy Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Postmenopausal Vaginal Atrophy Drugs Market Analysis by Regions

4.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

4.5 South America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

5 North America Postmenopausal Vaginal Atrophy Drugs by Countries

5.1 North America Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6 Europe Postmenopausal Vaginal Atrophy Drugs by Countries

6.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6.3 UK Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6.4 France Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs by Countries

7.1 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7.5 India Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

8 South America Postmenopausal Vaginal Atrophy Drugs by Countries

8.1 South America Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs by Countries

9.1 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

10 Global Postmenopausal Vaginal Atrophy Drugs Market Segment by Type

10.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue and Market Share by Type (2013-2018)

10.2 Premarin Sales Growth and Price

10.2.1 Global Premarin Sales Growth (2013-2018)

10.2.2 Global Premarin Price (2013-2018)

10.3 Vagifem Sales Growth and Price

10.3.1 Global Vagifem Sales Growth (2013-2018)

10.3.2 Global Vagifem Price (2013-2018)

10.4 Estrace Sales Growth and Price

10.4.1 Global Estrace Sales Growth (2013-2018)

10.4.2 Global Estrace Price (2013-2018)

10.5 Estring Sales Growth and Price

10.5.1 Global Estring Sales Growth (2013-2018)

10.5.2 Global Estring Price (2013-2018)

10.6 Femring Sales Growth and Price

10.6.1 Global Femring Sales Growth (2013-2018)

10.6.2 Global Femring Price (2013-2018)

11 Global Postmenopausal Vaginal Atrophy Drugs Market Segment by Application

11.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Application (2013-2018)

11.2 Vaginal Gels Sales Growth (2013-2018)

11.3 Creams Sales Growth (2013-2018)

11.4 Tablets Sales Growth (2013-2018)

11.5 Rings Sales Growth (2013-2018)

11.6 Patches Sales Growth (2013-2018)

12 Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.1 Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.2.2 Europe Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.2.4 South America Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

12.3 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Type (2018-2023)

12.4 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Postmenopausal Vaginal Atrophy Drugs Picture

Table Product Specifications of Postmenopausal Vaginal Atrophy Drugs

Figure Global Sales Market Share of Postmenopausal Vaginal Atrophy Drugs by Types in 2017

Table Postmenopausal Vaginal Atrophy Drugs Types for Major Manufacturers

Figure Premarin Picture

Figure Vagifem Picture

Figure Estrace Picture

Figure Estring Picture

Figure Femring Picture

Figure Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Applications in 2017

Figure Vaginal Gels Picture

Figure Creams Picture

Figure Tablets Picture

Figure Rings Picture

Figure Patches Picture

Figure United States Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Actavis plc Basic Information, Manufacturing Base and Competitors

Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bionovo, Inc. Basic Information, Manufacturing Base and Competitors

Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Endoceutics, Inc. Basic Information, Manufacturing Base and Competitors

Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors

Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors

Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Therapeutics MD, Inc. Basic Information, Manufacturing Base and Competitors

Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shionogi & Company Basic Information, Manufacturing Base and Competitors

Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Allergan plc Basic Information, Manufacturing Base and Competitors

Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Shionogi & Co. Ltd. Basic Information, Manufacturing Base and Competitors

Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Type and Applications

Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Manufacturer (2016-2017)

Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Manufacturer in 2016

Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Manufacturer in 2017

Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Manufacturer (2016-2017)

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Postmenopausal Vaginal Atrophy Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Postmenopausal Vaginal Atrophy Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Regions (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Regions (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Regions (2013-2018)

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions in 2013

Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions in 2017

Figure North America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Europe Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure South America Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table North America Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2013

Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017

Table North America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Table North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2013

Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017

Figure United States Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Canada Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table Europe Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Table Europe Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2016

Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017

Figure Germany Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure UK Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure France Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Russia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Italy Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries 2017

Figure China Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Japan Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Korea Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure India Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure South America Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table South America Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Figure South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017

Table South America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Table South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017

Figure Brazil Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure UAE Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Postmenopausal Vaginal Atrophy Drugs Sales and Growth Rate (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Type (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Type (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Type (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Type (2013-2018)

Figure Global Premarin Sales Growth (2013-2018)

Figure Global Premarin Price (2013-2018)

Figure Global Vagifem Sales Growth (2013-2018)

Figure Global Vagifem Price (2013-2018)

Figure Global Estrace Sales Growth (2013-2018)

Figure Global Estrace Price (2013-2018)

Figure Global Estring Sales Growth (2013-2018)

Figure Global Estring Price (2013-2018)

Figure Global Femring Sales Growth (2013-2018)

Figure Global Femring Price (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Application (2013-2018)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Application (2013-2018)

Figure Global Creams Sales Growth (2013-2018)

Figure Global Tablets Sales Growth (2013-2018)

Figure Global Rings Sales Growth (2013-2018)

Figure Global Patches Sales Growth (2013-2018)

Figure Global Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Regions (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Figure Europe Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Figure South America Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Postmenopausal Vaginal Atrophy Drugs Market Forecast (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Type (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Type (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Application (2018-2023)

Table Global Postmenopausal Vaginal Atrophy Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Actavis plc

Bionovo, Inc.

Endoceutics, Inc.

Novo Nordisk A/S

Pfizer Inc.

Teva Pharmaceuticals Ltd.

Therapeutics MD, Inc.

Shionogi & Company

Allergan plc

Shionogi & Co. Ltd.